Literature DB >> 15073528

VEGF protects human cerebral hybrid neurons from in vitro ischemia.

Moon-Ku Han1, Manho Kim, So Yon Bae, Lami Kang, So Young Han, Yong-Seok Lee, Jeong Ho Rha, Seung U Kim, Jae-Kyu Roh.   

Abstract

Vascular endothelial growth factor (VEGF), the most potent angiogenic peptide, protects the neurons against experimental ischemia. However, its neuroprotective effect on human brain is unknown. The present study attempted to determine whether VEGF can protect human cerebral neurons in vitro. A1 human hybrid clonal neurons (human cerebral neuron + neuroblastoma cell) were exposed to hypoxia with glucose deprivation. Pretreatment with VEGF reduced the A1 cell death, and VEGFR-2/Flk-1 and VEGF increased with a neuroprotective effect. However, the human neuroblastoma or neuroglioma cells failed to show these findings. Our results suggest that VEGF can protect human cerebral neurons from cell death after an ischemic insult in vitro, which is correlated to both increased expression of VEGFR-2/Flk-1 and VEGF within the cells.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15073528     DOI: 10.1097/00001756-200404090-00022

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  3 in total

1.  Changes in vascularization in substantia nigra pars compacta of monkeys rendered parkinsonian.

Authors:  C Barcia; V Bautista; A Sánchez-Bahillo; E Fernández-Villalba; B Faucheux; M Poza y Poza; A Fernandez Barreiro; E C Hirsch; M-T Herrero
Journal:  J Neural Transm (Vienna)       Date:  2005-01-24       Impact factor: 3.575

2.  LncRNA SNHG1 alleviates hypoxia-reoxygenation-induced vascular endothelial cell injury as a competing endogenous RNA through the HIF-1α/VEGF signal pathway.

Authors:  Shuangchao Liang; Kai Ren; Buying Li; Fangkuan Li; Zhuowen Liang; Jiqiong Hu; Bei Xu; Andong Zhang
Journal:  Mol Cell Biochem       Date:  2019-12-02       Impact factor: 3.396

3.  Naoluo Xintong Decoction Ameliorates Cerebral Ischemia-Reperfusion Injury by Promoting Angiogenesis through Activating the HIF-1α/VEGF Signaling Pathway in Rats.

Authors:  Pei-Pei Li; Ling He; Li-Miao Zhang; Xue-Mei Qin; Jian-Peng Hu
Journal:  Evid Based Complement Alternat Med       Date:  2022-04-11       Impact factor: 2.650

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.